COPD Clinical Trials near Dallas, TX
17 studies for COPD are recruiting at 40 sites within 50 miles of Dallas, Texas, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all COPD trials in the US or all trials near Dallas.
Recruiting now
COPD studies enrolling near Dallas
- A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
NCT06283966
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: Research Site (Dallas, TX); Research Site (Plano, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 5 sites within 50 mi
- A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
NCT07082738
- Phase 2
- Ages 40 years and older
- Sex: All
Nearest sites: Research Site (Dallas, TX); Research Site (Lewisville, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 50 mi
- eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
NCT07177339
- Phase 3
- Ages 40 to 75 years
- Sex: All
Nearest sites: GSK Investigational Site (Dallas, TX); GSK Investigational Site (Mesquite, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 50 mi
- Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
NCT07190209
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: Texas Health Presbyterian Hospital Dallas- Site Number : 8400032 (Dallas, TX); TEN20 Clinical Research - Carrollton- Site Number : 8400141 (Carrollton, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 50 mi
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
NCT06883305
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: Research Site (Dallas, TX); Research Site (Mansfield, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- STRIVE Post-Market Registry Study
NCT04302272
- Observational
- Ages 18 years and older
- Sex: All
Nearest sites: Baylor Scott & White Research Institute (Dallas, TX); University of Texas Southwestern (Dallas, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
NCT05181826
- Observational
- Ages 18 years and older
- Sex: All
Nearest sites: Liver Center of Texas (Dallas, TX); Methodist Hospital (Richardson, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
NCT06959095
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: GSK Investigational Site (Dallas, TX); GSK Investigational Site (McKinney, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
NCT07190222
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: IntraCare- Site Number : 8400034 (Dallas, TX); Medrasa Clinical Research - Wylie- Site Number : 8400124 (Wylie, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT07363694
- Phase 2/3
- Ages 35 to 80 years
- Sex: All
Nearest sites: Alina Clinical Trials, LLC. (Dallas, TX); Ten20 Clinical Research (Carrollton, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
NCT06035120
- Interventional
- Ages 40 to 80 years
- Sex: All
Nearest site: University of Texas Southwestern (Dallas, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
NCT06961214
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest site: GSK Investigational Site (Dallas, TX)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
NCT06878261
- Phase 3
- Ages 40 to 80 years
- Sex: All
Nearest sites: Research Site (Mesquite, TX); Research Site (Lewisville, TX)
- Distance to nearest recruiting site
- ~12 mi (city-level)
- Recruiting sites
- 3 sites within 50 mi
- A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT07759245
- Phase 2
- Ages 40 to 75 years
- Sex: All
Nearest site: Prime Clinical Research - Lewisville (Lewisville, TX)
- Distance to nearest recruiting site
- ~21 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
NCT07612878
- Observational
- Ages 40 years and older
- Sex: All
Nearest site: The Lung & Sleep Institute of North Texas (North Richland Hills, TX)
- Distance to nearest recruiting site
- ~25 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
NCT07646587
- Phase 2
- Ages 40 to 80 years
- Sex: All
Nearest sites: WB Contracted Clinical Research Site (Waxahachie, TX); WB Contracted Clinical Research Site (McKinney, TX)
- Distance to nearest recruiting site
- ~28 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
NCT07684820
- Phase 2
- Ages 40 to 85 years
- Sex: All
Nearest site: Metroplex Pulmonary and Sleep Center (McKinney, TX)
- Distance to nearest recruiting site
- ~31 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining a COPD clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.